Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart
about
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndromeThe neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytesACE2 gene expression is up-regulated in the human failing heartQuantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heartBlockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injuryPressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient micePhysiological antagonism of endothelin-1 in human conductance and resistance coronary arteryRapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overloadResponses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failureMaximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failureDifferential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors.Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide geneThe natriuretic peptides: physiology and role in left-ventricular dysfunction.Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes.Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosisAmeliorate Effects of Li-Fu Formula on IL-6-Mediated Cardiac Hypertrophy in Hamsters Fed with a Hyper-Cholesterol DietDivergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardiumVentricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodiesReversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism.The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.Induction of early biomarkers in a thrombus-induced sheep model of ischemic heart failureChanges in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.Genetics of hypertrophic cardiomyopathy: A review of current state.Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.Atrial natriuretic factor as a volume regulator.Atrial natriuretic peptide level contributes to a model of future mortality in the oldest old.Role of aldosterone in congestive heart failure.Atrophic cardiomyocyte signaling in hypertensive heart diseaseHDAC4 controls histone methylation in response to elevated cardiac load.The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes.Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.
P2860
Q24298270-69DE6024-BC92-4EAA-9EFF-915E80453B80Q24550992-DFF09860-E075-4189-B874-F41F8A81E3D5Q24794580-A5958EBC-9750-4B06-B961-E1C6C64CEB5AQ28282877-5F738315-0E1B-4E92-933B-A18EAEE9F989Q28344118-47AA1628-142B-4A99-9460-A390CD19A036Q28362795-FDA75A24-06C3-430B-ACE2-58A106ABC30BQ28366585-DAD94A67-0087-4CB7-A792-C85EE9A989ECQ28568167-F44E7FFB-DADF-4D0E-BF11-3C993126B817Q33614402-7CF290CC-1EE6-41F0-A459-A0F3CCDC1AFDQ33756693-F4D2DDCA-F083-4509-A8BD-6BAB49B74C7DQ33790096-2E6AEC7E-2B8E-470F-A39D-7CC3D72E3538Q34142903-3EF544A6-00D1-4E06-A7AC-C5ED87CEC3C5Q34171357-8341533C-3FA5-4AE5-A336-2686D75A5707Q34184637-54AD33D1-4E36-404A-9474-9E8DDCE7A003Q34207430-7E048682-DA67-4C3A-8815-955D47F63209Q34235642-319E6CCB-E60F-405C-B227-BCEFC2B0F1ADQ34409624-8468A2F6-B746-466B-9EA7-6924DB057C7FQ34448373-6A6E134E-D853-4AA8-86EB-6FFB1F357E9BQ35042890-CF0623CF-44B2-4E6A-95ED-3632049558E7Q35044504-295009B5-599D-4F73-9E96-132036FB0C58Q35064422-FDCA7FEB-6DAD-4462-B07D-0DBEF9D4DCE5Q35103217-1D67EC1D-8324-454A-A9AD-245EF3099899Q35762772-B144556A-7E9D-423E-B222-01C761962A70Q35832583-0872F289-F32A-48FF-84A3-1A6DE92205A5Q37051818-4273FE63-59B5-47CB-BEEA-7AA3A3B1A03CQ37114848-C6CE1AB1-254B-4167-994D-4B190292FC41Q37277937-11F14D5E-7B10-4CCC-9567-F1C0623E64C4Q37369965-AAF2EEF6-76C2-416A-BFBB-2B8B4850591EQ37374337-1726C54E-A856-474C-97F6-79F7C7830516Q38736063-1E8EDFF5-A55B-4700-983F-74A8D82899EDQ38815594-7525506B-6AED-4687-9551-6E854F7EE38FQ40340356-FFF7463B-443B-4A7E-87F9-13640BC0144DQ40341321-1A387946-2FA1-4762-ABB1-7B104DF7C7E5Q40625892-73F5E03B-FDE9-48D3-8B91-39175E38B8FFQ40861949-EE80F405-2301-4F27-AD52-6BAABBDE9F46Q40890503-E1D79681-CBE2-43DF-9C3D-3FB350D80D01Q41852121-6F95B8BE-2F75-49E3-A0EB-3DC8C1DFE950Q41992090-BF556F5E-500C-458B-9A17-60282278AEC2Q42014461-DCC90D6A-FF6E-4219-BF61-B706434DFA40Q42024979-D4D1417E-8CFD-46B0-BEE3-96685EAEAB8C
P2860
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Augmented expression of atrial ...... ntricle of human failing heart
@ast
Augmented expression of atrial ...... ntricle of human failing heart
@en
Augmented expression of atrial ...... ntricle of human failing heart
@nl
type
label
Augmented expression of atrial ...... ntricle of human failing heart
@ast
Augmented expression of atrial ...... ntricle of human failing heart
@en
Augmented expression of atrial ...... ntricle of human failing heart
@nl
prefLabel
Augmented expression of atrial ...... ntricle of human failing heart
@ast
Augmented expression of atrial ...... ntricle of human failing heart
@en
Augmented expression of atrial ...... ntricle of human failing heart
@nl
P2093
P2860
P356
P1476
Augmented expression of atrial ...... ntricle of human failing heart
@en
P2093
Fujiwara H
Nishimura K
Sugawara A
Takemura G
P2860
P304
P356
10.1172/JCI113872
P407
P577
1989-01-01T00:00:00Z